Berelowitz Michael 4/A
4/A · Recro Pharma, Inc. · Filed May 10, 2018
Insider Transaction Report
Form 4/AAmended
Berelowitz Michael
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-04+8,965→ 8,965 totalExercise: $11.32Exp: 2028-05-04→ Common Stock (8,965 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018.
- [F2]The stock option will vest on May 4, 2019.